Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |